Safety And Efficacy Of AN2728 Topical Ointment, 2% In Children, Adolescents, And Adults (Ages 2 Years And Older) With Atopic Dermatitis - Trial 2018-000731-27
Access comprehensive clinical trial information for 2018-000731-27 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2018-000731-27
Trial Details
EU Clinical Trials Register • 2018-000731-27
Safety And Efficacy Of AN2728 Topical Ointment, 2% In Children, Adolescents, And Adults (Ages 2 Years And Older) With Atopic Dermatitis
Study Focus
Sponsor & Location
Pfizer Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Success in ISGA, defined as an ISGA score of Clear (0) or Almost Clear (1) with at least a 2-grade improvement from Baseline.
ICD-10 Classifications
Atopic dermatitis
Atopic dermatitis, unspecified
Other atopic dermatitis
Acute atopic conjunctivitis
Allergic contact dermatitis
Data Source
EU Clinical Trials Register
2018-000731-27
Non-Device Trial